This page contains brief information about uridine triacetate and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
FDA label information for this drug is available at DailyMed.
Use in Cancer
Uridine triacetate is approved to be used in the emergency treatment of:
- Cardiac (heart) or central nervous system toxicity or other serious side effects within 4 days of ending treatment with fluorouracil or capecitabine.
- Overdoses of fluorouracil or capecitabine.
Uridine triacetate is also being studied in the treatment of other conditions.
More About Uridine Triacetate
Definition from the TCH Drug Dictionary – Detailed scientific definition and other names for this drug.
MedlinePlus Information on Uridine Triacetate – A lay language summary of important information about this drug that may include the following:
- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.
Clinical Trials Accepting Patients
Find Clinical Trials for Uridine Triacetate – Check for trials from TCH’s list of cancer clinical trials now accepting patients.